IRIS
PETRILLO, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.655
AS - Asia 3.424
SA - Sud America 2.273
EU - Europa 1.139
AF - Africa 149
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 13.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.484
BR - Brasile 2.033
SG - Singapore 1.744
CN - Cina 530
HK - Hong Kong 371
IT - Italia 319
VN - Vietnam 270
FR - Francia 165
UA - Ucraina 164
DE - Germania 133
AR - Argentina 88
TR - Turchia 75
BD - Bangladesh 74
GB - Regno Unito 68
MX - Messico 66
CA - Canada 54
EC - Ecuador 49
RU - Federazione Russa 49
UZ - Uzbekistan 41
ZA - Sudafrica 41
IN - India 40
ES - Italia 37
FI - Finlandia 36
JP - Giappone 35
IQ - Iraq 32
MA - Marocco 31
NL - Olanda 29
VE - Venezuela 25
PK - Pakistan 24
CO - Colombia 22
AZ - Azerbaigian 18
CL - Cile 18
KE - Kenya 17
PL - Polonia 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 16
AT - Austria 16
KR - Corea 15
ID - Indonesia 14
IE - Irlanda 14
SE - Svezia 14
AU - Australia 13
EG - Egitto 13
NP - Nepal 13
PE - Perù 13
BE - Belgio 12
JO - Giordania 12
KZ - Kazakistan 12
OM - Oman 10
PY - Paraguay 10
CR - Costa Rica 9
PS - Palestinian Territory 9
UY - Uruguay 9
DO - Repubblica Dominicana 8
DZ - Algeria 8
IL - Israele 8
LB - Libano 8
BY - Bielorussia 7
CH - Svizzera 7
JM - Giamaica 7
KW - Kuwait 7
RO - Romania 7
AO - Angola 6
CZ - Repubblica Ceca 6
GR - Grecia 6
HN - Honduras 6
PA - Panama 6
PH - Filippine 6
AL - Albania 5
KG - Kirghizistan 5
MY - Malesia 5
NI - Nicaragua 5
PR - Porto Rico 5
BH - Bahrain 4
BN - Brunei Darussalam 4
DK - Danimarca 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
RS - Serbia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
LT - Lituania 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
BG - Bulgaria 2
CG - Congo 2
CY - Cipro 2
EU - Europa 2
GE - Georgia 2
GF - Guiana Francese 2
GT - Guatemala 2
IR - Iran 2
MK - Macedonia 2
MU - Mauritius 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
BW - Botswana 1
Totale 13.641
Salva come PNG Salva come JPEG
Città #
Dallas 2.746
Singapore 1.011
Chandler 831
San Jose 657
Hong Kong 366
Ashburn 265
Princeton 240
Beijing 170
São Paulo 137
Lauterbourg 132
Wilmington 114
Ho Chi Minh City 96
The Dalles 91
Columbus 85
Shanghai 85
Rio de Janeiro 68
New York 65
Santa Clara 65
Hanoi 61
Los Angeles 52
Belo Horizonte 51
Council Bluffs 46
Tashkent 40
Frankfurt am Main 38
Brasília 36
Rome 34
Tokyo 34
Sassari 33
Salvador 31
Falls Church 29
Orem 29
Campinas 28
Helsinki 26
San Francisco 26
Curitiba 24
Guarulhos 24
Porto Alegre 24
Munich 21
Toronto 21
Norwalk 20
Brooklyn 19
Da Nang 18
Istanbul 17
Johannesburg 17
Manaus 17
Mexico City 17
Sorocaba 17
Quito 16
Baku 15
Boardman 15
Nairobi 15
Nuremberg 15
Ribeirão Preto 15
Seoul 15
Ankara 14
Atlanta 14
Campo Grande 14
Cape Town 14
Chicago 14
Contagem 14
Jacksonville 14
Amsterdam 13
Ann Arbor 13
Osasco 13
Praia Grande 13
Warsaw 13
Amman 12
Baghdad 12
Brussels 12
Chennai 12
Falkenstein 12
London 12
Manchester 12
Montreal 12
Recife 12
Uberlândia 12
Düsseldorf 11
Goiânia 11
Milan 11
Tianjin 11
Buffalo 10
Denver 10
Guayaquil 10
Houston 10
Santo André 10
Bogotá 9
Cotia 9
Dhaka 9
Montevideo 9
Rio Grande 9
Vila Velha 9
Volta Redonda 9
Boston 8
Caxias do Sul 8
Chengdu 8
Dublin 8
Florianópolis 8
Foz do Iguaçu 8
Haikou 8
Haiphong 8
Totale 8.684
Salva come PNG Salva come JPEG
Nome #
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 315
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project 314
Exploring Vascular Complications in Ovarian Cancer Surgery: A Narrative Literature Review with a New Management Proposal Algorithm 301
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 294
Short- and long-term outcomes of vaginal, laparoscopic, and robotic-assisted surgery in “oldest old” endometrial cancer 268
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study 180
Primary extranodal vaginal non-hodgkin lymphoma: Diagnostic pitfalls and therapeutic challenges 175
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 158
Materno-Fetal and Neonatal Complications of Diabetes in Pregnancy: A Retrospective Study 140
BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study 139
Efficacy and effectiveness of the bulking agents in the treatment of stress and mixed urinary incontinence: A systematic review and meta-analysis 137
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 137
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 137
Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis 137
Efficacy of HPV Vaccination in Women Receiving LEEP for Cervical Dysplasia: A Single Institution’s Experience 135
A case of isolated ovarian recurrence from vulvar carcinoma 134
Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma 133
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 131
A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 131
ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer 128
Assessing the long-term role of vaccination against hpv after loop electrosurgical excision procedure (Leep): A propensity-score matched comparison 128
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 127
Comparison of perioperative outcomes between standard laparoscopic and robotic-assisted approach in patients with rectosigmoid endometriosis 124
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 123
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study 118
High Incidence of Gestational Trophoblastic Disease in a Third-Level University-Hospital, Italy: A Retrospective Cohort Study 118
A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer 116
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 114
CD133 antigen expression in ovarian cancer 114
Conservatively treated glassy cell carcinoma of the cervix 113
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 112
Challenges in Gynecological Cancer: Biology, Diagnosis, Surgical, and Medical Treatment 107
The impact of COVID-19 lockdown on admission to gynecological emergency department: results from a a multicenter italian study 106
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 105
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: The experience at Gemelli hospital and a literature review 102
The role of surgery in platinum-resistant ovarian cancer: A call to the scientific community 100
Native tissue repair (NTR) versus transvaginal mesh interventions for the treatment of anterior vaginal prolapse: Systematic review and meta-analysis 99
The relevance of prelamin A and RAD51 as molecular biomarkers in cervical cancer 99
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 98
Fetal Growth and Neonatal Outcomes in Pregestational Diabetes Mellitus in a Population with a High Prevalence of Diabetes 98
Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer 97
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 97
Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma 96
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 95
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness 95
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer 95
Characteristics and outcomes of surgically staged multiple classifier endometrial cancer 94
Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia 94
Hospital costs incurred by the Italian National Health Service for invasive cervical cancer 93
Preoperative serum human epididymis protein 4 levels in early stage endometrial cancer: A prospective study 91
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer 91
Polarisation of tumor-associated macrophages toward M2 phenotype correlates with poor response to chemoradiation and reduced survival in patients with locally advanced cervical cancer 90
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up 89
Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series 86
Recurrence in skeletal muscle from squamous cell carcinoma of the uterine cervix: A case report and review of the literature 86
Self-reported long-term autonomic function after laparoscopic total mesometrial resection for early-stage cervical cancer: A multicentric study 86
Time trade-off procedure for measuring health utilities loss with human papillomavirus-induced diseases: A multicenter, retrospective, observational pilot study in Italy 86
Timing and pattern of recurrence in ovarian cancer patients with high tumor dissemination treated with primary debulking surgery versus neoadjuvant chemotherapy 85
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 85
Lidocaine spray vs mepivacaine local infiltration for suturing 1st/2nd grade perineal lacerations: a randomised controlled non-inferiority trial 84
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 84
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 84
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: Long-term results 84
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: Utility of a scoring system to predict outcomes 82
Ovarian low and high grade serous carcinomas: Hidden divergent features in the tumor microenvironment 81
Targeting the hallmarks of ovarian cancer: The big picture 81
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: A retrospective longitudinal analysis using matched tumor biopsies 81
Vulvar squamous cell carcinoma with sarcoma-like stroma: A case report and review of the literature 81
Glassy cell carcinoma of the endometrium: A case report and review of the literature 80
Novel targets for VEGF-independent anti-angiogenic drugs 80
Non-catalytic region of tyrosine kinase adaptor protein 2 (Nck2) pathways as factor promoting aggressiveness in ovarian cancer 80
Role of extracellular vesicles in epithelial ovarian cancer: A systematic review 80
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 79
HGF/c-Met axis drives cancer aggressiveness in the neo-adjuvant setting of ovarian cancer 79
Nek6 and Hif-1α cooperate with the cytoskeletal gateway of drug resistance to drive outcome in serous ovarian cancer 79
Feasibility and safety of laparoscopic approach in obese patients with endometriosis: a multivariable regression analysis 79
Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study 78
Influence of Intraperitoneal Dissemination Assessed by Laparoscopy on Prognosis of Advanced Ovarian Cancer: An Exploratory Analysis of a Single-Institution Experience 78
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 77
Incidence and predictive factors for complications after uterine leiomyoma embolization 77
Laparoscopic Versus Laparotomic Surgical Staging for Early-Stage Ovarian Cancer: A Case-Control Study 77
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study 77
Impact of postoperative cardiovascular complications on 30‐day mortality after major abdominal surgery: an international prospective cohort study 76
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy? 76
Epithelial ovarian cancer relapsing as isolated lymph node disease: Natural history and clinical outcome 76
Modulation of adipose-derived stem cell behavior by prostate pathology-associated plasma: insights from in vitro exposure 75
Postmenopausal recurrent cystitis treatment with intravesical hyaluronic acid and chondroitin sulphate: a patient-reported outcome study 75
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women’s compliance and satisfaction 75
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study 75
Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique 75
Expression and subcellular localization of CRH and its receptors in human endometrial cancer 74
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 74
Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients 73
Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer 73
Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients 73
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 72
Long-Term Survival for Platinum-Sensitive Recurrent Ovarian Cancer Patients Treated with Secondary Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy (HIPEC) 72
Survivin protein as predictor of pathologic response in patients with locally advanced cervical cancer treated with chemoradiation followed by radical surgery 70
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 70
Secondary cytoreduction in ovarian cancer: who really benefits? 70
Totale 10.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022561 14 7 9 13 25 22 11 46 61 49 68 236
2022/20231.454 151 54 20 266 128 248 2 211 286 12 50 26
2023/2024332 81 31 17 11 23 15 15 35 0 3 27 74
2024/20254.406 59 33 250 123 211 174 307 950 1.522 496 175 106
2025/20266.771 226 1.300 1.835 579 652 270 884 191 296 314 139 85
Totale 13.895